IT IS OFTEN DIFFICULT to decide when to intervene with operation in patients with long-standing aortic regurgitation.' Although indications vary, many clinicians only recommend operation when certain symptoms are present. This approach is based on the observation that when angina, syncope or congestive heart failure develop, prognosis over the next several years is poor.2-7 A corollary of this concept is that by not recommending operation until these symptoms occur, operative risk will be postponed, as will the long-term morbidity and mortality associated with existing prosthetic valves. Also, by postponing operation, the patient may benefit from subsequent improvements in operative technique and prosthetic valve design.
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The major drawback to this approach is that by the time angina, syncope or congestive heart failure develop, some patients have already suffered irreversible left ventricular dysfunction." [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Many of these patients develop severe congestive heart failure and die after operation, despite the elimination of aortic regurgitation. The present diagnostic challenge, therefore, is to identify the asymptomatic patient with aortic regurgitation just before irreversible left ven-tricular dysfunction occurs so that earlier operation can be undertaken." 9, 12, 14, 15, 17 Recently, we analyzed our experience with symptomatic patients who had aortic valve replacement for long-standing aortic regurgitation. 18 This analysis indicated that patients who died postoperatively of congestive heart failure had preoperative echocardiographic evidence of poor left ventricular systolic function. These data suggested that echocardiography might be useful for identifying patients who would benefit from earlier operative intervention.
Recommendations for earlier "prophylactic" operation that are based on echocardiographic observations in patients who had operation because of symptoms must be applied with caution to the asymptomatic patient. For example, if asymptomatic patients in the subgroup who might benefit from earlier operation do not cross into the high-risk group or develop severe symptoms for many years, it is reasonable to question the wisdom of earlier operation. However, if such patients develop symptoms and come to operation within a few years, a significant decrease in operative mortality or valve-related complications would probably not be realized by postponing operation. Hence, it is important to know the changes in echocardiographic measurements and symptomatic status that occur during the natural history of initially asymptomatic patients with aortic regurgitation. The present study was designed to provide this information and to elucidate the role of echocardiography in managing the patient with longstanding aortic regurgitation.
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Methods Patient Population
The patient population consisted of all patients with aortic regurgitation who had been followed in the Cardiology Clinic of the National Heart, Lung, and Blood Institute in whom two or more serial echocardiograms had been obtained over at least a 1-year period. Patients were considered to have aortic regurgitation if they had a blowing diastolic murmur at the base of the heart on physical examination and a left ventricular end-diastolic dimension by echocardiography that was above the normal range. No patient had a decreased carotid upstroke suggestive of aortic stenosis or an apical holosystolic murmur of mitral regurgitation. Also, no patient had echocardiographic evidence of mitral or aortic stenosis. All but one patient had highfrequency diastolic fluttering of the anterior leaflet of the mitral valve.
Initial echocardiographic evaluation of these patients was performed between January 1972 and December 1975. The minimum potential follow-up for any patient in this study was 26 months. When the initial evaluations were performed (and during the course of the study), operation was recommended for patients with aortic regurgitation only when patients presented with or developed severe dyspnea on exertion, angina pectoris, syncope or congestive heart failure. Thus, none of the patients had these symptoms at the time of initial study. In addition, none developed these symptoms (and, therefore, none came to operation) within 1 year after the initial examination.
Patient Studies
History, physical examination, 12-lead ECGs and M-mode echocardiograms were obtained in all patients at the initial and subsequent evaluations. Romhilt-Estes scores were computed from the ECGs as previously described.1' Cardiac catheterization data were available in every patient who subsequently came to operation.
Echocardiographic examination was performed using either an Ekoline 20A or Hoffrel 201 ultrasound transceiver interfaced to a Honeywell 1856 strip-chart recorder. A Patients were subdivided into two groups based on whether they developed symptoms and required operation or remained asymptomatic. Measurements in the two groups were compared using an unpaired t test.
Results
Patient Experience
Thirty-seven patients met the selection criteria and were included in the present study. There were 20 men and 17 women, ages 16- S. groups. However, the mean age of group was significantly less than sequent operation group (35.5 ± 11 13.1 years; p < 0.05). The echocardiographic data from summarized in figure 3 as a percentU value obtained using regression eq our laboratory from a large group older20 normal subjects.
Recent Evaluation
The mean values obtained at evaluation are also summarized in t operative group, left ventricular er sion did not change significantly dui 39 months that elapsed between the evaluations ( fig. 4 ). In the subs group, left ventricular end-systol The data were examined to determine the rate of change of left ventricular end-systolic dimension durall 37 patients are ing routine serial study. First, the absolute change was age of the expected computed for each patient by subtracting the value obuations derived in tained at initial examination from the value obtained of younger"9 and at the most recent examination. The average rate of change was then computed by dividing the absolute change by the time period between the initial and the most recent examination. The results of the average the most recent rate of change in end-systolic dimension are also .able 1. In the nonshown in figure 4 . The average rate of change exnd-systolic dimenceeded 4 mm per year in only one of the 37 patients ring the average of (3% End-systolic Dimension > 55 mm Of the five patients in this subgroup at initial evaluation, four (80%) developed symptoms and were recommended for operation within 22-57 months (mean 39 months) after initial study. The percentage of patients with an end-systolic dimension of at least 55 mm who developed symptoms and came to operation was significantly greater than the percentage of patients with an end-systolic dimension less than 50 mm who required operation (p < 0.05 by Fisher's exact test27). An additional two patients crossed into the > 55 mm subgroup during the study (fig. 4) weaker. Nor did we know how rapidly the end-systolic dimension changed during serial follow-up studies or whether this measurement could be used to identify patients who were likely to develop symptoms and require operation.
The results of the present study are relevant to these questions. We evaluated 37 patients who had isolated, chronic aortic regurgitation and had been followed for at least 1 year with two or more serial echocardiograms. At the initial evaluation, none of the patients had symptoms serious enough to warrant operation. Fourteen of the 37 patients (38%) subsequently developed either severe dyspnea on exertion, congestive heart failure, angina or syncope. Based on the development of symptoms, operation was recommended.
The echocardiographic and electrocardiographic measurements in these 14 patients were compared with measurements obtained in the 23 patients who have not developed symptoms and thus have not come to operation. Left ventricular end-systolic dimension and left ventricular fractional shortening were the measurements that on initial study most strongly distinguished patients who eventually required operation (table 1) . These measurements are highly correlated and both reflect systolic function.'8 Left ventricular end-diastolic dimension and the Romhilt-Estes score also separated the two groups, but with lower statistical significance.
When patients were subdivided based on their left ventricular end-systolic dimension, operation was required in four of the five patients (80%) with a left ventricular end-systolic dimension greater than 55 mm. The time between initial study and operation in these four patients averaged 39 months. Operation was also required in six of 12 patients (50%) with an endsystolic dimension of 50-54 mm during an average follow-up of 23 months. In contrast, only four of the 20 patients (20%) whose end-systolic dimension was less than 50 mm required operation ( fig. 5) .
Findings in our operative series of symptomatic patients with isolated aortic regurgitation are pertinent to these observations.'8 Approximately two-thirds of the operative patients had left ventricular end-systolic dimensions of 50 mm or greater at the time they developed symptoms and came to operation. Of the 17 operative patients with an end-systolic dimension less than 50 mm, seven (41%) had associated coronary artery disease ( fig. 6 ). In contrast, coronary disease was present in only three of the remaining 32 patients (9%) with end-systolic dimensions greater than 50 mm (p < 0.05 by Fisher's exact test27). Thus, when significant symptoms develop in patients with aortic regurgitation and left ventricular end-systolic dimension less than 50 mm, associated coronary disease is often present. Once this dimension is reached, half of initially asymptomatic patients with aortic regurgitation will develop symptoms and require operation during an average follow-up of 2-3 years.
Left ventricular end-systolic dimension may be markedly increased in some patients who do not complain of symptoms. Our experience with graded tread-mill exercise testing is consistent with this observation in that exercise tolerance may be only mildly impaired in many patients with aortic regurgitation, even when the left ventricule is very large and its systolic func-OPERATIVE GROUP The patients who remained asymptomatic during follow-up were significantly younger than those who developed symptoms and were recommended for operation.9 However, there was considerable overlap in the ages in the nonoperative and subsequent operation groups. Also, even relatively young patients (including two in their late twenties) presented with large, poorly contracting left ventricles.
The data in the present study were evaluated to determine the rate of change in left ventricular endsystolic dimension during routine clinical follow-up studies. These serial echocardiographic data demonstrated that it is very uncommon for the end-systolic dimension to increase more rapidly than 7 mm per year.
Before recommending that operation should be performed as soon as the end-systolic dimension exceeds 55 mm, it is important to examine the alternative, i.e., delaying operation until symptoms develop. One potential benefit of postponing operation is that improvements in operative techniques may reduce operative mortality. However, operative mortality was only 6% (excluding patients who required aortic root reconstruction) in our recent series of patients with isolated aortic regurgitation. This low operative mortality is similar to that noted in several other recent series.'2' 13, 17 Because six of seven patients (86%) with end-systolic dimensions greater than 55 mm developed symptoms and came to operation during an average follow-up of 30 months (including the two asymptomatic patients whose end-systolic dimension increased to more than 55 mm during serial study), it does not appear that operative risk will be significantly decreased by waiting until asymptomatic patients with end-systolic dimensions greater than 55 mm develop symptoms. Moreover, there is evidence in our operative series that the risk of operative damage may be increased in patients with very large left ventricular end-systolic dimensions.18 By waiting until symptoms develop in patients with large end-systolic dimension, one runs the risk that the end-systolic dimension may increase further and, as a result, the chances of operative damage may be increased and the likelihood of left ventricular function improving postoperatively may be decreased.
Another potential benefit of postponing operation is that improvements in prosthetic valve design will decrease late morbidity and mortality after valve replacement. For instance, if the present mortality due to valve malfunction were greater than the risk of developing congestive heart failure and dying, early intervention would be difficult to justify. However, in our recent operative series of symptomatic patients with either isolated aortic regurgitation,"8 or isolated aortic stenosis,28 only three of the combined total of 85 patients (4%) who survived operation died of valverelated complications. In contrast, nine of 17 sympto- matic patients (53%) operated upon for aortic regurgitation who had a preoperative left ventricular end-systolic dimension greater than 55 mm either died at operation or developed late postoperative congestive heart failure and died. These deaths occurred within 46 months of operation. If patients with both a preoperative end-systolic dimension greater than 55 mm and a fractional shortening less than 25% are considered, the likelihood of a poor result is further increased: 85% of such patients had a poor operative result. '8 Even if nonfatal valve complications, including anemia, cerebrovascular accidents, infection, poppet malfunction and perivalvular leak, are combined with the fatal valve complications (unpublished observations), the total incidence of all valve complications (20 of 85 patients or 24%) is still half (or less) of the congestive heart failure mortality in the high-risk groups. Therefore, it appears that postponing operation until symptoms develop in an asymptomatic patient with aortic regurgitation who has an endsystolic dimension greater than 55 mm results in a greater overall late mortality than the combined morbidity and mortality associated with prosthetic valve. Future improvements in prosthetic valve design will only strengthen this argument.
As a result of this information, we have changed our previous policy of recommending operation only to patients with aortic regurgitation who have severe dyspnea on exertion, congestive heart failure, angina or syncope. We still recommend operation to patients who present with or develop these symptoms during follow-up, regardless of the size or function of the left ventricle. Specifically, we do not withhold operation in patients with a left ventricular end-systolic dimension greater than 55 mm or a fractional shortening less than 25% for two reasons. First, a few patients with an end-systolic dimension greater than 55 mm had a significant increase in systolic function after operation. This was particularly true if preoperative fractional shortening was greater than 25%, but much less likely in patients whose fractional shortening was below 25%. 18 Second, a few patients with low preoperative systolic function that did not improve postoperatively are still doing reasonably well after several years of follow-up.
In contrast to our previous policy of only recommending operation to symptomatic patients, we now perform an extensive inpatient evaluation in all asymptomatic or minimally symptomatic patients who have a left ventricular end-systolic dimension by echocardiography of 55 mm or greater. Unless left ventricular cineangiography and radionuclide angiography29 are in major conflict with the echocardiographic data (a situation that, in our experience, is uncommon in patients with aortic regurgitation), we recommend operation, even in the absence of severe dyspnea on exertion, overt congestive heart failure, angina or syncope.
Asymptomatic patients with aortic regurgitation who have a left ventricular end-systolic dimension less than 50 mm are followed medically. In our previous operative study, we found that none of the patients who were in this subgroup died at operation or during postoperative follow-up, which averaged 4 years. '8 Therefore, there appears to be no reason to proceed with operation in such patients in the absence of symptoms, as long as patients are followed every 1-2 years. With this approach, some patients will develop symptoms requiring operation while maintaining good systolic function ( fig. 5 ) and should have an excellent long-term postoperative prognosis. Alternatively, some patients will develop progressive impairment of left ventricular systolic function before the onset of symptoms. If these patients are followed closely by serial echocardiographic studies, operation can be performed as soon as the patient manifests an endsystolic dimension of 55 mm or fractional shortening of 25%. Asymptomatic patients with severe aortic regurgitation who fall into the subgroup characterized by a left ventricular end-systolic dimension of 50-54 mm present a difficult therapeutic problem. If operation is performed in these patients, irreversible left ventricular dysfunction can probably be prevented. Only one of the 32 patients (3%) in our operative series '8 who had preoperative left ventricular end-systolic dimension of 55 mm or less developed congestive heart failure in the late postoperative period, and that patient, as mentioned previously, suffered an intraoperative myocardial infarction resulting in severe left ventricular dysfunction.
However, operating on patients within this subgroup before symptoms develop would have been potentially advantageous for only two of the 12 patients (19%); i.e., those who developed a left ventricular end-systolic dimension greater than 55 mm before coming to operation (figs. 4 and 5). Moreover, although six of 12 patients (50%) came to operation during an average follow-up of 23 months after the initial echocardiographic study, the other six (50%) are still asymptomatic after a follow-up of 2-5 years. Operation in these latter six patients would have been of questionable benefit. They would have been subjected prematurely to the risks of operation (6% operative risk in our series), as well as to the hazards inherent in a prosthetic valve. Thus, while operating on asymptomatic patients with aortic regurgitation whose left ventricular end-systolic dimension is 50-54 mm is not an unreasonable approach, the majority of such patients can be followed with only a small risk of developing irreversible left ventricular dysfunction before symptoms occur. Therefore, we do not recommend operation to asymptomatic patients in this subgroup.
With these considerations in mind, our current approach to the clinical management of the asymptomatic patient with chronic aortic regurgitation is to assess left ventricular size and function by serial echocardiograms. The frequency of examination and 
